Purchase Order 75F40118P10306
Award Date 9/2/18
Potential Completion Date 11/30/18
Potential Value $175K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78229, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Food and Drug Administration (FDA) to Cytobioscience, Inc. for an Automated Patch Clamp System for electrophysiology studies. The firm-fixed-price contract has a ceiling value of $160,570.00 and was awarded on September 16, 2015 with an ultimate completion date of October 28, 2015. The contract is not associated with a larger vehicle and does not have a set-aside designation. As the awardee, Cytobioscience, Inc. is the prime contractor for this...
- The Department of Health and Human Services Food and Drug Administration awarded a $727,122.40 firm fixed price purchase order to 3T Federal Solutions LLC of Austin, Texas. The contract calls for delivery of an automated high throughput patch clamp system to support the FDA's efforts to characterize drug effects on heart ion channels. The system must meet technical performance requirements to electrophysiologically assess individual cells at high volume, as requested in the small business...
- The U.S. Food and Drug Administration (FDA) awarded a $189,328.00 firm fixed-price purchase order to Govage, Inc., a small, minority-owned business based in Hazelwood, Missouri. The contract is for the procurement of Nanion consumables to perform ion channel pharmacology experiments using the SyncroPatch 384 automated patch clamp system. This contract was originally solicited as a total small business set-aside under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing). The...
- The U.S. Food and Drug Administration (FDA) awarded a $39,718.12 firm fixed-price purchase order to Nanion Technologies Inc., a small business, to provide consumables for the SyncroPatch 384 Automated High Throughput Patch Clamp System (HTS). This specialized scientific instrumentation supports cellular research, drug discovery, and biophysical studies by enabling the investigation of ion channels and membrane proteins. Nanion Technologies Inc. has a long history of providing advanced biomedical...
- The Food and Drug Administration (FDA) awarded a $346,227.62 firm-fixed-price purchase order contract to Nanion Technologies Inc., a for-profit scientific instrumentation company, for a 5-year service maintenance plan for a SyncroPatch 384 system. The contract will provide preventative maintenance, technical support, software upgrades, and repairs for the equipment at the FDA facility in Silver Spring, Maryland. This contract was competed without a set-aside designation. The primary products and...
- This is a $90,324.00 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Nanion Technologies Inc., a small business vendor. The contract is for the provision of a Real Time Cell Analysis Cardio System to support the monitoring of drug-induced cardiotoxicity. The system will be used to perform advanced cellular research and drug discovery studies at the FDA's facilities in Silver Spring, Maryland. The contract was set aside for small business competition,...
- This is a $1,945,000.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Health and Environmental Sciences Institute (HESI), a non-profit organization based in Washington, DC. The contract is for assessing the variability and reproducibility of manual and automated patch clamp platforms, which are used to evaluate drug safety and biological activity. The contract does not have a set-aside designation and has an ultimate completion date of December 31,...
- The Department of Health and Human Services' Food and Drug Administration awarded a $120,000 firm fixed price purchase order to Global Life Sciences Solutions USA LLC for a BIACORE 1K+ Upgrade Kit. The prime contractor, a subsidiary of Danaher Corporation, will provide the upgrade kit to support the FDA's work. Performance will take place in Marlborough, Massachusetts over approximately one year. No set aside designation or subcontractors were indicated. The award falls under HHS/FDA programs...
- The Food and Drug Administration (FDA) awarded a $336,000 firm fixed-price purchase order to Pacific Biosciences of California, Inc. on August 21, 2015, for Part Number 100-236-400, a standard PacBio service contract with a base period and four option years. The contract was completed on July 22, 2019, with performance undertaken at the contractor's facility in Menlo Park, California. No set-aside designation was applied to this award. Pacific Biosciences is a leading biotechnology company...
- The Department of Health and Human Services' Food and Drug Administration awarded a firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for an INCUCYTE S3 LIVE-CELL ANALYSIS SYSTEM or equivalent. The $134,622.30 contract will be performed in Herndon, Virginia and supports the FDA's Division of Applied Regulatory Science in studying the chronic effects of drugs on cell cultures containing human organ features. Government Scientific Source Inc. is a leading...
The Department of Health and Human Services Food and Drug Administration awarded a $175,000.00 firm fixed price purchase order to Cytobioscience, Inc., a for-profit organization, to upgrade the agency's in-house automated patch clamp system. The contract was awarded on September 2, 2018, with a completion date of November 30, 2018. The contract was not set aside for any specific socioeconomic category.
Generated 3/23/24, 5:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $175.0k | 9/2/18 |